Möchten Sie immer auf dem neuesten Stand bleiben?

MELBOURNE, AUSTRALIA--(Marketwired - Jul 7, 2014) -  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the number of...

CAMBRIDGE, MA--(Marketwired - Jun 30, 2014) - Proteostasis Therapeutics, Inc., a developer of novel therapeutics regulating protein homeostasis to improve outcomes for patients with orphan and...

BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new...

BRISBANE, AUSTRALIA--(Marketwired - Jun 5, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, announced today that they expect to report the top-line results from the...

MELBOURNE, AUSTRALIA--(Marketwired - May 28, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce the appointment of Mr Eutillio Buccilli to the role of Chief...

MELBOURNE, AUSTRALIA--(Marketwired - May 16, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today the completion of a series of transactions with the Company's largest...

MELBOURNE, AUSTRALIA--(Marketwired - Apr 30, 2014) - Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) today announced it has filed its Quarterly Activities Report for the Quarter ended March...

MELBOURNE, AUSTRALIA--(Marketwired - Apr 17, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that an Extraordinary General Meeting of shareholders was held at 10.00 am today...

BRISBANE, AUSTRALIA--(Marketwired - Apr 7, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that it will be presenting proprietary data at the American...

MELBOURNE, AUSTRALIA--(Marketwired - Mar 24, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today that in compliance with the ASX Continuous Disclosure Rules, the company...